MedTrace Logo

Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2

NCT00514657 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 91

Last updated 2007-08-10

No results posted yet for this study

Summary

The present clinical trial clarified that basic fibroblast growth factor-2 (FGF-2) can induce regeneration of periodontal tissue lost by progression of periodontitis and evaluated the safety of such induction.

Conditions

  • Periodontitis

Interventions

DRUG

Trafermin (genetical recombinant of human basic Fibroblast Growth Factor)

Sponsors & Collaborators

  • Kaken Pharmaceutical

    lead INDUSTRY

Principal Investigators

  • Makoto Tamura, Ph.D · Kaken Pharmaceutical Co., Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-12-31
Completion
2004-02-29

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00514657 on ClinicalTrials.gov